MedTech Strategist's complimentary Community Blog focuses on the people and the passions that drive the global medical device industry. Sign up for our e-Newsletter to receive new articles and video interviews directly to your inbox.
e-Newsletter Browse
New device-based interventions for AAA may offer an alternative to prolonged surveillance in treating abdominal aortic aneurysms. Excerpted from our recent MTS feature, "Living Under Surveillance: Can New AAA Treatments Change the Story?"
FDA provides more details on the draft MDUFA VI agreement. Excerpted from Pathways Picks July 15: America First" Fees, Remote Monitoring Restrictions, Aussie Advertising Code, and More.
New device-based interventions for AAA may offer an alternative to prolonged surveillance in treating abdominal aortic aneurysms. Excerpted from our recent MTS feature, "Living Under Surveillance: Can New AAA Treatments Change the Story?"
FDA provides more details on the draft MDUFA VI agreement. Excerpted from Pathways Picks July 15: America First" Fees, Remote Monitoring Restrictions, Aussie Advertising Code, and More.